Molecular and Cellular Microbiology / Biomedical Sciences : Antifungal Activity of Salvia miltiorrhiza Against Candida albicans Is Associated with the Alteration of Membrane Permeability and (1,3)-β-D-Glucan Synthase Activity = Molecular and Cellular Microbiology / Biomedical Sciences : Antifungal Activity of Salvia miltiorrhiza Against Candida albicans Is Associated with the Alteration of Membrane Permeability and (1,3)-β-D-Glucan Synthase Activity

다국어 초록 (Multilingual Abstract)

Candidiasis has posed a serious health risk to immunocompromised patients owing to the increase in resistant yeasts, and Candida albicans is the prominent pathogen of fungal infections. Therefore, there is a critical need for the discovery and characterization of novel antifungals to treat infections caused by C. albicans. In the present study, we report on the antifungal activity of the ethanol extract from Salvia miltiorrhiza against C. albicans and the possible mode of action against C. albicans. The increase in the membrane permeability was evidenced by changes in diphenylhexatriene binding and release of both 260-nm-absorbing intracellular materials and protein. In addition, inhibition of cell wall synthesis was demonstrated by the enhanced minimal inhibitory concentration in the presence of sorbitol and reduced (1,3)-β-D-glucan synthase activity. The above evidence supports the notion that S. miltiorrhiza has antifungal activity against C. albicans by the synergistic activity of targeting the cell membrane and cell wall. These findings indicate that S. miltiorrhiza displays effective activity against C. albicans in vitro and merits further investigation to treat C. albicansassociated infections.

참고문헌 (Reference)

1 한용문, "Tanshinone 단삼성분의 전신성 캔디다증에 대한 항균효과" 대한약학회 57 (57): 119-124, 2013

2 Dufourc EJ, "Sterols and membrane dynamics" 1 : 63-77, 2008

3 Shapiro RS, "Regulatory circuitry governing fungal development, drug resistance, and disease" 75 : 213-267, 2011

4 Clinical Laboratory Standards Institute, "Reference method for broth dilution antifungal susceptibility testing of yeasts"

5 Adams JD, "Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions" 1 : 3-, 2006

6 Cowan MM, "Plant products as antimicrobial agents" 12 : 564-582, 1999

7 Parks LW, "Physiological implications of sterol biosynthesis in yeast" 49 : 95-116, 1995

8 Khan MSA, "Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans" 3 : 54-, 2013

9 Lin TH, "Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction" 5 : 22-27, 2010

10 Shapiro HM, "Parameters and probes" Wiley 229-, 1995

11 Wang S, "Orientational distribution of 1,6-diphenyl-1,3,5-hexatriene in phospholipid vesicles as determined by global analysis of frequency domain fluorimetry data" 30 : 5565-5572, 1991

12 Krcmery V, "Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance" 50 : 243-260, 2002

13 Carson CF, "Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy" 46 : 1914-1920, 2002

14 Kurtz M, "Lipopeptide inhibitors of fungal glucan synthase" 35 : 79-86, 1997

15 Munro S, "Lipid rafts: elusive or illusive" 115 : 377-388, 2003

16 Pfaller MA, "Invasive fungal pathogens: current epidemiological trends" 43 : S3-S14, 2006

17 Repáková J, "Influence of DPH on the structure and dynamics of a DPPC bilayer" 88 : 3398-3410, 2005

18 Marczak A, "Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde" 74 : 236-239, 2009

19 Pfaller MA, "Epidemiology of invasive candidiasis: a persistent public health problem" 20 : 133-163, 2007

20 Varona R, "Effect of papulacandin B on β-glucan synthesis in Schizosaccharomyces pombe" 20 : 243-247, 1983

21 Zhao J, "Diterpenoid tanshinones and phenolic acids from cultured hairy roots of Salvia miltiorrhiza Bunge and their antimicrobial activities" 16 : 2259-2267, 2011

22 Ghannoum MA, "Dimorphism-associated variations in the lipid composition of Candida albicans" 132 : 2367-2375, 1986

23 Aricha B, "Differences in membrane fluidity and fatty acid composition between phenotypic variants of Streptococcus pneumoniae" 186 : 4638-4644, 2004

24 Sung B, "Cytotoxic effects of solvent-extracted active components of Salvia miltiorrhiza B unge on h uman c ancer cell lines" 9 : 1421-1428, 2015

25 Liu M, "Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeast" 42 : 325-329, 2007

26 White TC, "Clinical, cellular, and molecular factors that contribute to antifungal drug resistance" 11 : 382-402, 1998

27 Vandeputte P, "Antifungal resistance and new strategies to control fungal infections" 1 (1): 2012

28 Carrillo-Muñoz AJ, "Antifungal agents: mode of action in yeast cells" 19 : 130-139, 2006

29 Gray KC, "Amphotericin primarily kills yeast by simply binding ergosterol" 109 : 2234-2239, 2012

30 Han JY, "Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion" 117 : 280-295, 2008

31 Li YG, "Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen)" 1216 : 1941-1953, 2009

32 Frost DJ, "A wholecell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly" 48 : 306-310, 1995

33 Shedletzky E, "A microtiter-based fluorescence assay for (1,3)-β-glucan synthases" 249 : 88-93, 1997